If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks close higher on Wall St, airlines bounce

Thu, 28th Jan 2021 09:16

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Airlines gain on short squeeze in AAL

* EU warns it could block vaccine exports

* Spike in volatility hits equities
(Updates to market close)

By Sruthi Shankar and Joice Alves

Jan 28 (Reuters) - European stocks closed higher on Thursday
as a bounce in Wall Street stocks, gains in airlines and upbeat
earnings reports drove a reversal of early losses across
markets.

After falling as much as 2% in morning trade, the
pan-European STOXX 600 rose 0.1% by the close, leaving
the benchmark with small gains for the year.

The German DAX gained 0.3%, France's CAC 40
was up 0.9% and Britain's exporter-heavy FTSE fell 0.6%,
coming under pressure from a rise in the pound.

Stocks globally saw a spike in volatility this week as a
retail trading frenzy hit markets in the United States, Europe
and Asia, inflating value in certain stocks that major hedge
funds have bet against.

Wall Street jumped on gains in technology stocks, while
American Airlines surged more than 20% at one point
after the U.S. carrier was mentioned on Reddit's WallStreetBets
forum following its results.

European travel names like Lufthansa, TUI
and British Airways-owner IAG rose between 4.7% and
7.2%. Wizz Air and easyJet rose more than 4.5%
each despite posting a double-digit decline in fourth-quarter
revenue.

"UK airlines are tracking a short squeeze in American
Airlines brought on by r/WallStreetBets after it released Q4
earnings," said Jasper Lawler, head of research at LCG. "AA has
abnormally high short interest but other airlines do too given
the state the industry is in."

Other European stocks that were highly bid this week, like
CD Projekt, Ambu and Varta,
extended gains, while Nokia tumbled 13%.

Investors looked past strong earnings from Apple
and Facebook as well as the U.S. Federal Reserve's pledge
to stick to loose monetary policy as worries about slow rollout
of COVID-19 vaccines and more curbs in Europe dampened the mood.

"With valuations at levels already pricing in much of the
recovery from a pandemic that is far from over, these
corrections are always possible," Ian Williams, economics and
strategy research analyst at Peel Hunt said in a note.

Germany is preparing entry restrictions for travellers from
Britain, Brazil and South Africa, and its health minister
expects the current shortage of coronavirus vaccines to continue
well into April.

Meanwhile, the European Union warned drug companies such as
AstraZeneca that it would use all legal means or even
block exports unless they agreed to deliver shots as promised.

The world's largest spirits maker Diageo rose 3%
after it reported a surprise rise in underlying net sales growth
in the first half of the year, helped by strong U.S. demand.

Swedish medical equipment maker Getinge jumped 9%
after reporting strong quarterly results as it saw a spike in
demand in 2020 for ventilators and other advanced life support
equipment due to the pandemic.
(Reporting by Sruthi Shankar in Bengaluru and Joice Alves in
London; Editing by Arun Koyyur and Mark Heinrich)

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.